Prognosis prediction and drug guidance of ovarian serous cystadenocarcinoma through mitochondria gene-based model
To summarize, we established a novel 7 MRGs - based risk score model that could be utilized for prognosis prediction and chemosensitivity assessment in OSC patients.
Authors
- Meiyi Chen (ORCID: https://orcid.org/0000-0003-1761-9232)
- Dongsheng Shen (ORCID: https://orcid.org/0000-0002-0872-835X)
- Huaifang Li (ORCID: https://orcid.org/0000-0002-9496-7145)
- Zhenghu Chen (ORCID: https://orcid.org/0000-0003-0342-1233)
- Xiaowen Tong (ORCID: https://orcid.org/0000-0003-4872-1678)
- Chenghao Wu (ORCID: https://orcid.org/0000-0002-6515-0988)
- Zixuan Zhou
- Yi Guo
Institutions
- Tongji University (CN)
- International Peace Maternity & Child Health Hospital (CN)
- Burn Institute (US)
- Shanghai East Hospital (CN)
- Shanghai University of Medicine and Health Sciences (CN)
- Tongji Hospital (CN)
Publication Details
- Journal
- Cancer Genetics
- Published
- 2024-12-29
- DOI
- https://doi.org/10.1016/j.cancergen.2024.12.005
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Natural Science Foundation of China
- Shanghai University of Medicine and Health Sciences
- China National Funds for Distinguished Young Scientists
- National Key Research and Development Program of China